SRPT
Sarepta Therapeutics Inc
NASDAQ: SRPT · HEALTHCARE · BIOTECHNOLOGY
$20.67
-1.90% today
Updated 2026-04-29
Market cap
$2.18B
P/E ratio
—
P/S ratio
0.99x
EPS (TTM)
$-7.13
Dividend yield
—
52W range
$10 – $65
Volume
2.9M
Sarepta Therapeutics Inc (SRPT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $115291.00 | $10.99M | $21.26M | $17.59M | $29.42M | $46.99M | $37.33M | $14.22M | $9.76M | $1.25M | $5.42M | $154.58M | $301.03M | $380.83M | $540.10M | $701.89M | $933.01M | $1.24B | $1.90B | $2.20B |
| Revenue growth (YoY) | — | +9428.2% | +93.5% | -17.3% | +67.3% | +59.7% | -20.6% | -61.9% | -31.4% | -87.2% | +332.6% | +2751.6% | +94.7% | +26.5% | +41.8% | +30.0% | +32.9% | +33.3% | +53.0% | +15.6% |
| Cost of revenue | $31.01M | $42.08M | $35.95M | $31.71M | $27.46M | $35.93M | $51.93M | $90.28M | $94.10M | $146.19M | $130000.00 | $7.35M | $34.19M | $56.59M | $63.38M | $97.05M | $139.99M | $150.34M | $319.10M | $881.50M |
| Gross profit | $115291.00 | $10.99M | $21.26M | $17.59M | $1.96M | $11.06M | $-14.60M | $-76.06M | $-84.35M | $1.25M | $5.29M | $147.23M | $266.84M | $324.25M | $476.72M | $604.84M | $793.02M | $1.09B | $1.58B | $1.32B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 6.7% | 23.5% | -39.1% | -535.0% | -864.5% | 100.0% | 97.6% | 95.2% | 88.6% | 85.1% | 88.3% | 86.2% | 85.0% | 87.9% | 83.2% | 59.9% |
| R&D | $25.35M | $34.76M | $29.00M | $24.40M | $35.97M | $66.86M | $52.40M | $72.91M | $94.23M | $146.39M | $188.27M | $166.71M | $401.84M | $560.91M | $722.34M | $771.18M | $877.09M | $877.39M | $804.52M | $1.52B |
| SG&A | $7.75M | $9.33M | $9.80M | $8.70M | $14.38M | $16.05M | $14.63M | $31.59M | $49.31M | $75.04M | $81.20M | $119.85M | $209.98M | $284.81M | $317.88M | $282.66M | $451.42M | $481.87M | $557.87M | $478.94M |
| Operating income | $-32.98M | $-33.11M | $-27.46M | $-15.51M | $-20.93M | $-35.93M | $-29.70M | $-90.28M | $-133.79M | $-220.18M | $-266.73M | $-171.64M | $-343.63M | $-705.56M | $-564.16M | $-459.71M | $-536.20M | $-267.82M | $218.08M | $-657.77M |
| Operating margin | -28608.5% | -301.4% | -129.2% | -88.2% | -71.2% | -76.5% | -79.6% | -635.0% | -1371.2% | -17572.5% | -4920.3% | -111.0% | -114.1% | -185.3% | -104.5% | -65.5% | -57.5% | -21.5% | 11.5% | -29.9% |
| EBITDA | $-30.89M | $-25.15M | $-22.48M | $-14.13M | $-19.47M | $-34.63M | $-27.59M | $-88.42M | $-129.97M | $-214.94M | $-261.12M | $-34.76M | $-316.66M | $-658.71M | $-453.38M | $-317.41M | $-594.85M | $-453.69M | $316.89M | $-647.97M |
| EBITDA margin | -26795.4% | -229.0% | -105.8% | -80.3% | -66.2% | -73.7% | -73.9% | -621.8% | -1332.1% | -17153.8% | -4816.8% | -22.5% | -105.2% | -173.0% | -83.9% | -45.2% | -63.8% | -36.5% | 16.7% | -29.5% |
| EBIT | $-32.98M | $-27.17M | $-23.95M | $-15.51M | $-20.93M | $-35.93M | $-29.12M | $-89.69M | $-133.66M | $-220.18M | $-266.73M | $-42.85M | $-328.90M | $-683.21M | $-493.12M | $-355.42M | $-636.72M | $-498.09M | $279.17M | $-692.49M |
| Interest expense | $0.00 | $0.00 | $344000.00 | $454000.00 | $344000.00 | $90000.00 | $0.00 | $326000.00 | $0.00 | $1.36M | $535000.00 | $5.78M | $33.71M | $30.67M | $59.95M | $63.52M | $53.25M | $22.01M | $18.39M | $9.73M |
| Income tax | — | $-5.94M | $6.41M | $9.65M | $11.24M | $-34.91M | $91.58M | $20.42M | $-1.69M | $-5.25M | $-7.62M | $2.06M | $-692000.00 | $1.20M | $1.06M | $-168000.00 | $13.53M | $15.88M | $25.54M | — |
| Effective tax rate | 0.0% | 17.9% | -36.5% | -62.2% | -53.7% | 93.8% | -308.3% | -22.3% | 1.2% | 2.3% | 2.8% | -4.2% | 0.2% | -0.2% | -0.2% | 0.0% | -2.0% | -3.1% | 9.8% | 0.0% |
| Net income | $-31.07M | $-27.17M | $-23.95M | $-25.16M | $-32.18M | $-2.32M | $-121.29M | $-111.98M | $-135.79M | $-220.03M | $-267.26M | $-50.69M | $-361.92M | $-715.08M | $-554.13M | $-418.78M | $-703.49M | $-535.98M | $235.24M | $-713.41M |
| Net income growth (YoY) | — | +12.6% | +11.8% | -5.0% | -27.9% | +92.8% | -5132.4% | +7.7% | -21.3% | -62.0% | -21.5% | +81.0% | -614.0% | -97.6% | +22.5% | +24.4% | -68.0% | +23.8% | +143.9% | -403.3% |
| Profit margin | -26951.8% | -247.3% | -112.7% | -143.1% | -109.4% | -4.9% | -324.9% | -787.6% | -1391.7% | -17560.3% | -4930.2% | -32.8% | -120.2% | -187.8% | -102.6% | -59.7% | -75.4% | -43.1% | 12.4% | -32.5% |